Pharmacist Prometric & Licensing Exam 2026: Complete Syllabus, Passing Marks and Study Guide (DHA, MOHAP, DOH, SCFHS, Oman, Qatar DHP, NHRA, Kuwait MOH)

If you are a BPharm, BSc Pharmacy or PharmD graduate planning to work as a Pharmacist in the Middle East, your licensing pathway will depend on the country and health authority you are applying to. Most major Gulf regulators require a computer-based pharmacist licensing examination, but the question count, duration, passing standard, eligibility rules and post-exam licensing steps are not identical.

This guide covers the major Middle East health authorities and explains the eligibility requirements, exam format, syllabus, reference books and licensing pathways relevant to Pharmacist applicants.

1. What is the Pharmacist Licensing Exam?

The Pharmacist licensing examination assesses whether a pharmacy graduate has the pharmaceutical-science knowledge, clinical judgement, calculation skills, medication-safety awareness and professional-practice competence required for safe pharmacy practice. Across the Middle East, the assessment commonly integrates pharmaceutical sciences, pharmacology and toxicology, pharmacokinetics, compounding, therapeutics, over-the-counter care, pharmacy law, medication safety and patient-centred decision-making.

Question type: Computer-based single-best-answer multiple-choice questions are used by the major licensing systems covered in this guide. The exact blueprint and weighting vary by authority.

Language: English. Prometric and Pearson VUE pharmacist licensing examinations covered by this guide are conducted in English.

Delivery: Computer-based testing through Prometric, Pearson VUE or another authority-approved platform. Oman also requires an oral VIVA step in the pharmacist licensing pathway after the written examination.

Result: Reporting varies by authority. Some regulators issue a percentage or scaled score, while others issue Pass/Fail with a score report or authority-specific result format.

Attempts: Authority-specific. The UAE Unified PQR provides three examination attempts across the UAE Authorities. SCFHS uses its current Saudi professional licensure-exam attempt policy, Qatar allows five consecutive attempts for the pharmacist qualifying exam, and Bahrain permits four initial licensure-exam attempts within three years.

2. Middle East Health Authorities and Regulatory Pathways for Pharmacists

Each regulator has its own pharmacist licensing route, and a pharmacist licence issued by one authority is not automatically valid in another jurisdiction. The table below summarises the principal pathway across the authorities covered by this guide.

3. Pharmacist Passing Marks and Exam Format

Pharmacist examination specifications differ across Middle East regulators. Across DHA, MOHAP and DOH, the same UAE Pharmacist specification applies: 150 MCQs in 3 hours with a 60% pass mark. Saudi Arabia, Oman, Qatar and Bahrain use their own licensing structures.

*Qatar note: the current DHP qualifying-examination page and Prometric page list Pharmacist as 150 MCQs in 3 hours with a 60% pass mark, while the updated 2025 National Pharmacist Qualifying Examination blueprint states 150 MCQs in 3.5 hours. Candidates should follow the duration shown on their current booking confirmation. The 2025 blueprint also updates the content distribution to 7 Basic Biomedical Sciences items, 38 Pharmaceutical Sciences, 38 Social/Behavioral/Administrative Sciences and 67 Clinical Sciences.

4. Eligibility Criteria for Pharmacists

The exact eligibility requirements differ by regulator. A recognised pharmacy degree is the common foundation, but the required experience, professional registration, examination exemptions and post-exam licensing steps vary by jurisdiction.

UAE qualification: The UAE Unified PQR recognises BSc in Pharmacy or Doctor of Pharmacy for the Pharmacist title.

UAE experience: Two years of post-qualification pharmacy experience in the related field is required for the Pharmacist title. Experience gained only in pharmaceutical-company or sales-representative roles is not accepted for this purpose.

Clinical Pharmacy is a separate title: A PharmD or postgraduate clinical-pharmacy qualification may support the Clinical Pharmacist pathway, but candidates should not assume that every PharmD applicant is automatically licensed under the generic Pharmacist or Clinical Pharmacist title without authority evaluation.

Saudi Arabia: SCFHS uses the Saudi Pharmacist Licensure Examination (SPLE) for professional practice licensing. The current SPLE is a national licensing examination rather than the specialist classification-style exam used for many physician and dental specialties.

Qatar: DHP requires a Bachelor’s Degree in Pharmacy plus two years of post-graduate experience for the standard Pharmacist scope, together with the qualifying exam unless an approved exemption applies. A pharmacy-related master’s degree may qualify for exam exemption under the published pharmacist guidelines.

Oman: The Oman MOH pharmacist evaluation pathway requires the written OEP/Prometric certificate, DataFlow/credential verification, a pharmacy registration document and at least three years of experience for the published non-Omani evaluation route; a VIVA is also required before licensing.

Bahrain: NHRA’s published Pharmacy PQR requires BSc Pharmacy applicants who are non-Bahraini to have five years of post-certification experience; a six-year PharmD that includes the required hospital internship route may qualify with two years of experience. The Bahrain Pharmacy Licensure Examination is required unless an exemption applies.

Professional licence and Good Standing: A current professional licence/registration and Good Standing documentation are commonly required. Primary-source verification of education, experience and professional registration may also be mandatory.

Primary Source Verification: DataFlow or another approved verification provider may be used depending on the regulator. Qatar and the UAE explicitly require credential verification within their licensing workflows, and Oman requires verified qualification and experience documents for the pharmacist evaluation route.

Examination exemption is not uniform. UAE, Qatar, Saudi Arabia, Bahrain and Oman apply different rules, and advanced degrees do not create one universal exemption. Candidates should wait for the target regulator’s eligibility/evaluation decision before assuming that an examination is waived.

5. Pharmacist Syllabus and Core Study Areas Across Middle East Health Authorities

The 14 study areas below follow the UAE Pharmacist examination coverage and map closely to the current SCFHS and Qatar national pharmacist blueprints. SCFHS groups the examination into Basic Biomedical Sciences (10%), Pharmaceutical Sciences (35%), Social/Behavioral/Administrative Sciences (20%) and Clinical Sciences (35%). Qatar’s 2025 NPQE similarly uses four major sections but places the greatest emphasis on Clinical Sciences. The framework below therefore preserves the UAE topic structure while remaining suitable for broader Middle East preparation.

Topic 1: Toxicology

Acute and chronic drug toxicity, overdose recognition, toxidromes, decontamination principles, antidotes, poison-information resources, toxic alcohols, acetaminophen/salicylate toxicity, cardiotoxic and neurotoxic drugs, organophosphate poisoning and monitoring of poisoned patients.

Topic 2: Medicinal Chemistry

Drug structure-activity relationships, physicochemical properties, functional groups, stereochemistry, ionisation, solubility, metabolism-related structural changes and the relationship between chemical structure, receptor interaction, potency, selectivity and adverse effects.

Topic 3: Sterile and Nonsterile Compounding

Aseptic technique, sterile admixtures, hazardous-drug handling, clean-room principles, beyond-use dating, compatibility, stability, extemporaneous preparations, calculations, labeling, quality control and prevention of contamination and compounding errors.

Topic 4: Pharmaceutics and Biopharmaceutics

Dosage-form design, routes of administration, dissolution, absorption, bioavailability, bioequivalence, controlled-release systems, formulation stability, excipients, drug-delivery systems and the effect of dosage-form properties on therapeutic performance.

Topic 5: Pharmacognosy and Dietary Supplements

Natural products, herbal medicines, vitamins and minerals, common dietary supplements, pharmacologic activity, evidence of efficacy, toxicity, herb-drug interactions, contraindications and counseling on safe complementary-product use.

Topic 6: Pharmacy Calculations and Compounding

Dose and concentration calculations, dilutions, alligation, infusion rates, body-weight and body-surface-area dosing, renal-dose calculations, electrolyte and osmolar calculations, quantity-to-dispense problems and calculation checks that prevent medication error.

Topic 7: Clinical Pharmacogenomics

Common gene-drug relationships, pharmacogenetic testing, altered drug metabolism or response, high-yield CYP-related interactions, HLA-associated reactions and practical use of pharmacogenomic information in selecting or adjusting therapy.

Topic 8: Infection Control and Antimicrobial Stewardship

Standard precautions, hand hygiene, aseptic handling, infection prevention in pharmacy practice, antimicrobial selection principles, resistance, de-escalation, dose optimisation, IV-to-oral conversion, prophylaxis and pharmacist responsibilities in antimicrobial stewardship.

Topic 9: Pharmacokinetics and Therapeutic Drug Monitoring

Absorption, distribution, metabolism and excretion; clearance, volume of distribution, half-life, steady state, loading and maintenance doses, linear/nonlinear kinetics, renal/hepatic impairment and therapeutic monitoring of drugs such as vancomycin, aminoglycosides, digoxin, lithium and antiepileptics.

Topic 10: Pharmaceutical Care and Disease-State Management

Patient assessment and evidence-based pharmacotherapy across common cardiovascular, endocrine, respiratory, infectious, gastrointestinal, neurologic, psychiatric and renal disorders; treatment goals, monitoring parameters, adherence and prevention of drug-related problems.

Topic 11: Medication Safety

Prescription review, reconciliation, high-alert medicines, look-alike/sound-alike drugs, dosing errors, contraindications, interactions, adverse drug reactions, pharmacovigilance, error reporting, safe transitions of care and systems approaches to medication-error prevention.

Topic 12: Over-the-Counter Medication and Self-Care

Assessment of minor ailments, selection of nonprescription therapy, red-flag symptoms, contraindications, special populations, counseling, referral criteria and safe use of analgesics, cough/cold products, gastrointestinal medicines, topical agents, smoking-cessation products and common self-care treatments.

Topic 13: Pharmacy Law, Ethics and Professional Practice

Prescription legality, controlled and restricted medicines, dispensing responsibilities, documentation, confidentiality, consent, professional boundaries, ethical dilemmas, scope of practice, regulatory compliance and culturally appropriate communication with patients and healthcare professionals.

Topic 14: Clinical Pharmacology and Therapeutic Decision-Making

Mechanism of action, indications, contraindications, adverse effects and interactions of major drug classes; interpretation of laboratory data; individualisation of therapy in pregnancy, lactation, pediatrics, geriatrics and organ dysfunction; evidence-based drug information and patient counseling.

Cross-Authority Focus: The Same Core Pharmacy Competencies Are Grouped Differently

The UAE blueprint presents 14 practical pharmacy topics, whereas SCFHS and Qatar organise the same knowledge into four broad domains. In the current SPLE, Pharmaceutical Sciences and Clinical Sciences each carry 35%, Social/Behavioral/Administrative Sciences 20% and Basic Biomedical Sciences 10%. Qatar’s 2025 NPQE shifts even more weight toward Clinical Sciences, with 67 of 150 items. This means strong clinical pharmacotherapy and medication-safety reasoning should be combined with solid pharmaceutics, calculations, pharmacokinetics and professional-practice knowledge.

6. Recommended Reference Books

The UAE Pharmacist examination guideline lists nine core references. The current SCFHS and Qatar pharmacist blueprints overlap substantially with these resources and add newer clinical, pharmacokinetic and pharmacy-practice sources. Candidates should use the latest available editions wherever possible:

Dick R. Gourley and James C. Eoff III, The APhA Complete Review for Pharmacy. Broad review source covering biomedical, pharmaceutical and practice topics.

Lippincott Illustrated Reviews: Biochemistry, latest edition. Core biomedical-science and biochemical foundation for pharmacy practice.

Comprehensive Pharmacy Review by Leon Shargel and colleagues, latest edition. Broad examination review across pharmaceutics, pharmacology, calculations and therapeutics.

Goodman & Gilman’s The Pharmacological Basis of Therapeutics, latest edition. Core pharmacology, mechanisms, adverse effects and therapeutic principles.

Applied Biopharmaceutics & Pharmacokinetics by Shargel and colleagues, latest edition. Core pharmacokinetics, bioavailability, bioequivalence and dosage-regimen reference.

Pharmaceutical Calculations by Howard C. Ansel and colleagues, latest edition. Core calculations and compounding mathematics reference.

Aulton’s Pharmaceutics: The Design and Manufacture of Medicines, latest edition. Modern reference for dosage forms, formulation, stability and drug-delivery systems.

Principles of Toxicology by Karen E. Stine and Thomas M. Brown, latest edition. Core toxicology principles and mechanisms.

Essentials of Pharmacoeconomics by Karen Rascati, latest edition. Core pharmacoeconomic and health-outcomes concepts relevant to administrative pharmacy sciences.

Beyond textbook study, exam-day preparation benefits from high-quality MCQ practice. The Pharmacist MCQ bank on prometricguide.com is designed around the 14-topic cross-authority framework above and includes 2500 plus questions with detailed explanations covering pharmaceutical sciences, calculations, therapeutics, medication safety, law and professional practice.

7. Two Ways We Can Help You Get Licensed

Prometric Guide supports Pharmacist exam preparation across the Middle East, while our sister company Alzantra International supports the UAE licensing process.

For Exam Preparation: Prometric Guide (All Middle East Authorities)

Whether you are targeting DHA, MOHAP, DOH Abu Dhabi, SCFHS Saudi Arabia, OMSB Oman, Qatar DHP, NHRA Bahrain or Kuwait MOH, our Pharmacist MCQ bank provides one broad preparation base covering the core pharmacy knowledge shared across these licensing destinations:

2500 plus Pharmacist MCQs mapped to the 14-topic cross-authority framework.

Detailed explanations with references to APhA, Comprehensive Pharmacy Review, Goodman & Gilman, Shargel, Aulton, current pharmacotherapy sources and authority blueprints.

Free introductory mock tests and topic-wise practice sets.

High-yield coverage of calculations, pharmaceutics, pharmacology, pharmacokinetics, therapeutics, OTC care, medication safety, compounding, pharmacy law and clinical decision-making.

Access on any device, unlimited attempts.

Explore the full Pharmacist exam preparation package on prometricguide.com.

For UAE Licensing Paperwork: Alzantra International (DHA, MOHAP, DOH)

For UAE licensing, Alzantra International supports Pharmacist candidates targeting Dubai, the Northern Emirates and Abu Dhabi with documentation and licensing coordination.

DataFlow / primary-source verification of the pharmacy degree, professional licence and experience.

DHA Sheryan Pharmacist application and assessment coordination for Dubai.

MOHAP Pharmacist evaluation and licensing application for the Northern Emirates.

DOH Abu Dhabi Pharmacist application through TAMM.

Pharmacy qualification, professional registration, experience and supporting-document preparation guidance.

Eligibility submission, tracking and follow-up.

CBT or additional assessment coordination where required.

Pharmacist licence activation and UAE facility/employer licensing support.

Contact Alzantra International at www.alzantra.ae or [email protected] for UAE licensing support. For SCFHS/Saudi Arabia, Oman, Qatar DHP, NHRA Bahrain and Kuwait MOH, use the relevant regulator’s official pathway.

8. Frequently Asked Questions

What is the passing score for the Pharmacist exam?

For DHA, MOHAP and DOH, the Pharmacist exam is 150 MCQs in 3 hours with a 60% pass mark. SCFHS uses a scaled SPLE passing score of 536 on the 200-800 reporting scale. Qatar DHP publishes 60%. NHRA Bahrain publishes 60% for its licensure examinations. Oman and Kuwait should be followed according to the current exam/eligibility instructions issued to the candidate.

Am I eligible with a BPharm, BSc Pharmacy or PharmD?

In the UAE, BSc Pharmacy and Doctor of Pharmacy are recognised qualification routes for the Pharmacist title, with two years of related post-qualification experience. Qatar also accepts a Bachelor’s Degree in Pharmacy for the standard Pharmacist scope with two years of experience. Other authorities apply their own degree, internship, registration and experience rules.

How many questions are in the Pharmacist exam?

DHA, MOHAP and DOH use 150 MCQs in 3 hours. The Saudi SPLE contains 200 questions in two 120-minute blocks with a scheduled 30-minute break. Qatar uses 150 questions; its live page states 3 hours while the 2025 blueprint states 3.5 hours. Oman uses the OEP through Pearson VUE, but the current OMSB public page does not state a fixed question count.

Which reference books should I use?

The UAE guideline lists APhA Complete Review for Pharmacy, Lippincott Biochemistry, Comprehensive Pharmacy Review, Goodman & Gilman, Applied Biopharmaceutics & Pharmacokinetics, Pharmaceutical Calculations, Aulton’s Pharmaceutics, Principles of Toxicology and Essentials of Pharmacoeconomics. Current SCFHS and Qatar blueprints add modern clinical-pharmacy, pharmacokinetic and evidence-based practice resources.

Can I complete the exam from my home country?

Often yes. SCFHS SPLE and UAE/Qatar Prometric examinations are offered through international testing networks, while OMSB states that Omani Occupational Classification examinations are available at Pearson VUE centres worldwide. Availability depends on the eligibility and test-centre options shown during scheduling.

How is the Saudi SPLE different?

The current SPLE contains 200 questions divided into two 100-question blocks of 120 minutes each, with a scheduled 30-minute break. Up to 10% may be pilot items. The passing score is 536 on a 200-800 scale. Its blueprint allocates 10% to Basic Biomedical Sciences, 35% to Pharmaceutical Sciences, 20% to Social/Behavioral/Administrative Sciences and 35% to Clinical Sciences.

How many attempts do I get?

Attempt rules vary. UAE examinations follow the Unified PQR three-attempt framework. The current SCFHS professional-practice policy generally provides the first attempt plus two further attempts if the candidate does not pass, with rules for future opportunities; Qatar permits five consecutive attempts for the pharmacist qualifying exam. Bahrain permits four initial attempts within three years before retraining provisions apply.

Does every Middle East authority use the same Pharmacist exam?

No. The UAE uses PHO5481, Saudi Arabia uses the SPLE, Oman uses the OEP and requires a VIVA in the licensing pathway, Qatar uses its National Pharmacist Qualifying Examination, Bahrain uses the BPLE/NHRA licensure route, and Kuwait regulates pharmacy through its own MOH pharmacy structure.

Is Pharmacist the same as Clinical Pharmacist?

No. In several Gulf licensing systems, Pharmacist and Clinical Pharmacist are separate professional titles. Clinical Pharmacist usually requires a PharmD, clinical-pharmacy residency or postgraduate clinical-pharmacy qualification plus the experience defined by the regulator. Apply under the title that matches your actual qualification and practice scope.

What is the best MCQ bank for Pharmacist exam preparation?

The Pharmacist MCQ bank on prometricguide.com includes 2500 plus questions aligned to the 14-topic cross-authority framework, with detailed explanations covering pharmaceutical sciences, calculations, pharmacokinetics, pharmacotherapy, compounding, OTC care, medication safety, law and professional practice.

9. Final Thoughts

Pharmacist is a regulated healthcare profession across all major Middle East jurisdictions, but the licensing examination and post-exam pathway are not uniform. The UAE uses a common PHO5481 specification, Saudi Arabia uses the national SPLE, Oman uses the OEP plus a VIVA step, Qatar uses the NPQE, Bahrain uses the BPLE/NHRA pathway, and Kuwait regulates pharmacy through its dedicated MOH pharmacy structure.

Prepare around the complete pharmacy scope: pharmaceutical sciences, pharmacology, toxicology, calculations, pharmaceutics, pharmacokinetics, compounding, clinical pharmacotherapy, OTC care, medication safety, infection control, pharmacy law, ethics and patient-centred decision-making. Final revision should be matched to the authority-specific blueprint and exam format assigned to you.

Prometric Guide supports Pharmacist candidates preparing across the major Middle East health authorities.